Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 DNA damage, p53 and anticancer therapies.

× No keyword cloud information.

13 in total

1. Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53.

Authors: A L Okorokov; F Ponchel; J Milner
Journal: EMBO J Date: 1997-10-01 Impact factor: 11.598

2. TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer.

Authors: Daniela Kandioler; Ronald Zwrtek; Carmen Ludwig; Elisabeth Janschek; Meinhard Ploner; Friedrich Hofbauer; Irene Kührer; Sonja Kappel; Friedrich Wrba; Manfred Horvath; Josef Karner; Karl Renner; Michael Bergmann; Judith Karner-Hanusch; Richard Pötter; Raimund Jakesz; Bela Teleky; Friedrich Herbst
Journal: Ann Surg Date: 2002-04 Impact factor: 12.969

3. DNA mismatch repair enzyme hMSH2 in malignant melanoma: increased immunoreactivity as compared to acquired melanocytic nevi and strong mRNA expression in melanoma cell lines.

Authors: K Rass; P Gutwein; C Welter; V Meineke; W Tilgen; J Reichrath
Journal: Histochem J Date: 2001-08

4. Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations.

Authors: R K Brachmann; K Yu; Y Eby; N P Pavletich; J D Boeke
Journal: EMBO J Date: 1998-04-01 Impact factor: 11.598

5. Beta-irradiation used for systemic radioimmunotherapy induces apoptosis and activates apoptosis pathways in leukaemia cells.

Authors: Claudia Friesen; Annelie Lubatschofski; Jörg Kotzerke; Inga Buchmann; Sven N Reske; Klaus-Michael Debatin
Journal: Eur J Nucl Med Mol Imaging Date: 2003-06-26 Impact factor: 9.236

6. Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability.

Authors: P V Nikolova; J Henckel; D P Lane; A R Fersht
Journal: Proc Natl Acad Sci U S A Date: 1998-12-08 Impact factor: 11.205

7. Induction of an apoptotic program in cell-free extracts by 2-chloro-2'-deoxyadenosine 5'-triphosphate and cytochrome c.

Authors: L M Leoni; Q Chao; H B Cottam; D Genini; M Rosenbach; C J Carrera; I Budihardjo; X Wang; D A Carson
Journal: Proc Natl Acad Sci U S A Date: 1998-08-04 Impact factor: 11.205

8. Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrate.

Authors: Maria A Mariggiò; Sergio Cafaggi; Massimo Ottone; Brunella Parodi; Maria O Vannozzi; Vaclav Mandys; Maurizio Viale
Journal: Invest New Drugs Date: 2004-01 Impact factor: 3.850

9. In vitro study on apoptosis induced by strontium-89 in human breast carcinoma cell line.

Authors: Cheng Wang; Jing Wang; Han Jiang; Min Zhu; Baoguo Chen; Weiguang Bao
Journal: J Biomed Biotechnol Date: 2011-06-09

10. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.

Authors: Chaitali Tophkhane; Shi-He Yang; Yunbo Jiang; Zhikun Ma; Dharmalingam Subramaniam; Shrikant Anant; Shingo Yogosawa; Toshiyuki Sakai; Wan-Guo Liu; Susan Edgerton; Ann Thor; Xiaohe Yang
Journal: PLoS One Date: 2012-08-30 Impact factor: 3.240